Arena Pharmaceuticals Inc Ár/értékesítés
Mi az Arena Pharmaceuticals Inc Ár/értékesítés?
A Ár/értékesítés az Arena Pharmaceuticals Inc - 112,536.89
Mi a Ár/értékesítés meghatározása?
Az ár / árbevétel arány a vállalat részvényeinek árbevételéhez képest.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Ár/értékesítés a Health Care szektor a NASDAQ-on cégekben a Arena Pharmaceuticals Inc -hoz képest
Mit csinál Arena Pharmaceuticals Inc?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
ár/értékesítés -hoz hasonló cégek Arena Pharmaceuticals Inc
- Sphinx Resources nak Ár/értékesítés 67,525.38 van
- BELLUS Health nak Ár/értékesítés 84,667.69 van
- Altius Renewable Royalties nak Ár/értékesítés 86,180.13 van
- Andhra Cements nak Ár/értékesítés 87,119.67 van
- Tamboran Resources Ltd nak Ár/értékesítés 99,124.18 van
- Magnetic Resources NL nak Ár/értékesítés 112,397.36 van
- Arena Pharmaceuticals Inc nak Ár/értékesítés 112,536.89 van
- Aurcana nak Ár/értékesítés 127,420.23 van
- HFX nak Ár/értékesítés 129,126.97 van
- Jindal Photo nak Ár/értékesítés 150,074.98 van
- Talon Metals nak Ár/értékesítés 157,309.73 van
- Nimy Resources Ltd nak Ár/értékesítés 174,464.42 van
- Grand Fortune High Grade nak Ár/értékesítés 184,615.38 van